Join to View Full Profile
3248 Westbourne DrCincinnati, OH 45248
Phone+1 513-674-1400
Fax+1 513-206-1902
Dr. Heile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Michael Heile, MD is a Family Medicine specialist based in Cincinnati, OH. He completed his medical degree at the University of Cincinnati College of Medicine in 1994 and his Family Medicine residency at St Elizabeth Medical Center from 1994-1997. His notable contributions to multiple publications have been significantly cited, with main research interests surrounding Type 2 Diabetes Mellitus. Dr. Heile garners many awards, earning recognitions from National Committee for Quality Assurance, Epic Systems Corporation and the Health Care Incentives Improvement Institute, demonstrating proficiency in delivering patient-centered, quality care.
Education & Training
St Elizabeth Medical CenterResidency, Family Medicine, 1994 - 1997
University of Cincinnati College of MedicineClass of 1994
Certifications & Licensure
IN State Medical License 2017 - 2027
OH State Medical License 1997 - 2026
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 13 citationsAutomated Insulin Delivery: Easy Enough to Use in Primary Care?Michael Heile, Betty Hollstegge, Laura Broxterman, Albert Cai, Kelly L. Close
Clinical Diabetes. 2020-12-01 - The evidence for oral semaglutide in type 2 diabetes from a managed care perspective.Michael Heile, Patty Taddei-Allen
The American Journal of Managed Care. 2020-12-01 - 6 citationsType 2 diabetes in the US managed care setting: the burden of disease and rationale for an oral glucagon-like peptide-1 receptor agonist.Tanya Dougherty, Michael Heile
The American Journal of Managed Care. 2020-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
